ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 2094

$921K Total Retail Price of All Prescriptions

Rank: 115 out of 2094

442 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 8,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
CARVEDILOL 416 330 1 19
ZOLPIDEM TARTRATE 389 294 2 14
OMEPRAZOLE 335 266 3 4
AMLODIPINE BESYLATE 321 236 4 2
METFORMIN HCL 285 226 5 8
PLAVIX 282 233 6 38
CRESTOR 248 182 7 15
MELOXICAM 232 188 8 49
DIOVAN 215 137 9 13
SIMVASTATIN 198 155 10 1
ATORVASTATIN CALCIUM 196 161 11 5
OXYCODONE-ACETAMINOPHEN 180 92 S2 12 40
CLOPIDOGREL 178 147 13 22
LOSARTAN POTASSIUM 169 126 14 17
DIOVAN HCT 166 127 15 28
CLOTRIMAZOLE-BETAMETHASONE 166 71 15 91
RAMIPRIL 165 139 17 48
PROAIR HFA 164 96 18 45
ALENDRONATE SODIUM 163 144 19 30
BISOPROLOL-HYDROCHLOROTHIAZIDE 159 114 20 148
LEVOTHYROXINE SODIUM 153 114 21 3
DICLOFENAC SODIUM 149 99 22 168
JANUMET 138 87 23 86
NEXIUM 135 113 24 16
ENALAPRIL MALEATE 128 112 25 25
FAMOTIDINE 119 82 26 34
NABUMETONE 119 69 26 203
GLIMEPIRIDE 118 100 28 31
GLYBURIDE-METFORMIN HCL 115 89 R 29 94
BIDIL 115 80 10 29 234
LISINOPRIL 110 96 31 7
FUROSEMIDE 107 76 32 6
GABAPENTIN 107 88 32 23
CLOBETASOL PROPIONATE 100 63 34 160
JANUVIA 96 63 35 35
ADVAIR DISKUS 96 55 35 36
METOPROLOL TARTRATE 96 76 35 10
SINGULAIR 87 70 38 64
HYDROXYZINE HCL 83 56 R 39 232
ACETAMINOPHEN-CODEINE 82 62 S3 40 129
MECLIZINE HCL 81 69 41 103
TAMSULOSIN HCL 78 58 42 29
SOLARAZE 77 54 43 278
CHLORHEXIDINE GLUCONATE 76 44 44 319
AZOR 72 28 45 155
LOVAZA 72 34 45 53
TRAMADOL HCL-ACETAMINOPHEN 71 56 47 100
ENDOCET 71 43 S2 47 88
AMOX TR-POTASSIUM CLAVULANATE 71 49 47 107
IBUPROFEN 69 34 50 73
TRAMADOL HCL 68 57 51 33
ACTOS 68 56 51 112
HYDROCHLOROTHIAZIDE 67 48 53 12
LOSARTAN-HYDROCHLOROTHIAZIDE 66 56 54 52
ESCITALOPRAM OXALATE 65 55 55 46
POLYETHYLENE GLYCOL 3350 63 52 56 75
TIZANIDINE HCL 62 41 57 254
FEXOFENADINE HCL 62 58 57 191
ZETIA 62 41 57 79
METOCLOPRAMIDE HCL 59 45 60 141
LYRICA 59 45 60 85
LIPITOR 58 41 62 39
LANSOPRAZOLE 53 40 63 144
AZITHROMYCIN 52 24 64 27
NIASPAN 51 30 65 145
FLUTICASONE PROPIONATE 50 37 66 41
PREDNISONE 50 24 66 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.